The present invention relates to a liquid formulation comprising (i) a
botulinum toxin, (ii)
human serum albumin (HSA), and optionally (iii) a
tonicity agent and / or (iv) a buffer. In one aspect, the liquid formulation is characterized by a very low iron
ion concentration. In another aspect, the liquid formulation is characterized by containing no or very low concentrations of
tryptophan and / or N-acetyl-
tryptophan. According to the invention, the liquid formulation can be prepared by a method comprising the steps of contacting
human serum albumin with a chelating agent to obtain a mixture, and removing the chelating agent from the mixture. Furthermore, the present invention relates to the use of said liquid formulations in the treatment of indications and cosmetic conditions.